Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

FDA To Study DTC Promotion Directed at Adolescents
Focus is on Immediate Benefits vs. Deferred Risks

The Adolescent Brain"Adolescents are a unique audience for DTC drug marketing because their cognitive abilities are different than those of adults," noted the FDA in an October, 2013, Federal Register notice to conduct an "Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents" (FR # FDA-2013-N-1151). Yet some pharmaceutical companies are promoting powerful drugs to teens on the Web and on TV.

FDA's proposed study will have adolescents and their parents view a DTC promotional campaign for either a fictitious Attention Deficit Hyperactivity Disorder (ADHD) medication or a fictitious acne medication. The study will explore similarities and differences in perceptions for these matched pairs. This article is a review of that study, which aims to assess how adolescents interpret drug risk in DTC advertising.

Topics include (partial list):
  • Examples of Drugs Marketed to Teens
  • FDA's Research Into Teen-Targeted DTC Ads
  • The Adolescent Brain
  • Shire's Comments
Download the full text PDF file here:
www.pharma-mkting.com/news/pmnews1310-article02.pdf


PMN1310-02
Issue: Vol. 13, No. 10: December 2014

Find other articles in related Topic Areas:

Vol 13, #10 Contents






Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.